nmm 22 4500ICPSR06845MiAaIm f a u cr mn mmmmuuuu150303s1997 miu f a eng d(MiAaI)ICPSR06845MiAaIMiAaI
National Household Survey on Drug Abuse, 1982
[electronic resource]
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
2015-02-03Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1997ICPSR6845NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, and personal and family income sources and amounts. Half of the respondents were asked questions regarding substance use by close friends. Demographic data include gender, race, age, ethnicity, educational level, job status, income level, veteran status, household composition, and population density. Youth respondents were also asked about time spent on homework and leisure activities.
Cf.: http://doi.org/10.3886/ICPSR06845.v3
alcoholicpsrdrugsicpsrhallucinogensicpsrheroinicpsrhouseholdsicpsrmarijuanaicpsrmethamphetamineicpsrprescriptions drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsralcohol abuseicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrdemographic characteristicsicpsrdrug abuseicpsrdrug useicpsrSAMHDA I. National Survey on Drug Use and Health (NSDUH)RCMD V. Health and Well-BeingICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemNAHDAP I. National Addiction and HIV Data Archive ProgramNACJD XI. Drugs, Alcohol, and CrimeRCMD I. CrimeUnited States Department of Health and Human Services. National Institutes of Health. National Institute on Drug AbuseInter-university Consortium for Political and Social Research.ICPSR (Series)6845Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR06845.v3 nmm 22 4500ICPSR06128MiAaIm f a u cr mn mmmmuuuu150303s1993 miu f a eng d(MiAaI)ICPSR06128MiAaIMiAaI
National Household Survey on Drug Abuse, 1991
[electronic resource]
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
2015-02-03Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1993ICPSR6128NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
This series measures the prevalence and correlates of drug
use in the United States. The surveys are designed to provide
quarterly, as well as annual, estimates. Information is provided on
the use of illicit drugs, alcohol, anabolic steroids, and tobacco
among members of United States households aged 12 and older. Data are
also provided on treatment for drug use and on illegal activities
related to drug use. Questions include age at first use, as well as
lifetime, annual, and past-month usage for the following drug classes:
marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco,
and nonmedical use of psychotherapeutics. Respondents were also asked
about problems resulting from their use of drugs, alcohol, and
tobacco, their perceptions of the risks involved, insurance coverage,
and personal and family income sources and amounts. Demographic data
include gender, race, ethnicity, educational level, job status, income
level, household composition, and population density.
Cf.: http://doi.org/10.3886/ICPSR06128.v2
cocaineicpsrcrimeicpsrdemographic characteristicsicpsrdrug abuseicpsrdrug useicpsrdrugsicpsrhallucinogensicpsrheroinicpsrhouseholdsicpsrinhalantsicpsrmarijuanaicpsrmethamphetamineicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrNACJD XI. Drugs, Alcohol, and CrimeSAMHDA I. National Survey on Drug Use and Health (NSDUH)ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemNAHDAP I. National Addiction and HIV Data Archive ProgramRCMD I. CrimeRCMD V. Health and Well-BeingUnited States Department of Health and Human Services. National Institutes of Health. National Institute on Drug AbuseInter-university Consortium for Political and Social Research.ICPSR (Series)6128Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR06128.v2 nmm 22 4500ICPSR06843MiAaIm f a u cr mn mmmmuuuu150303s1998 miu f a eng d(MiAaI)ICPSR06843MiAaIMiAaI
National Household Survey on Drug Abuse, 1979
[electronic resource]
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
2015-02-03Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1998ICPSR6843NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, inhalants, alcohol, tobacco, nonmedical use of prescription drugs including psychotherapeutics, and polysubstance use. Respondents were also asked about their knowledge of drugs, perceptions of the risks involved, population movement, and sequencing of drug use. Fifty-seven percent of respondents were asked specific questions about their perceptions of the consequences of marijuana and alcohol use. The other 43 percent were asked about heroin use among friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, and household composition.
Cf.: http://doi.org/10.3886/ICPSR06843.v4
heroinicpsrtobacco useicpsralcoholicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrtranquilizersicpsryouthsicpsrmarijuanaicpsrmethamphetamineicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrdemographic characteristicsicpsrdrug abuseicpsrdrug useicpsrdrugsicpsrhallucinogensicpsrhouseholdsicpsrinhalantsicpsrRCMD V. Health and Well-BeingNAHDAP I. National Addiction and HIV Data Archive ProgramNACJD XI. Drugs, Alcohol, and CrimeRCMD I. CrimeSAMHDA I. National Survey on Drug Use and Health (NSDUH)ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemUnited States Department of Health and Human Services. National Institutes of Health. National Institute on Drug AbuseInter-university Consortium for Political and Social Research.ICPSR (Series)6843Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR06843.v4 nmm 22 4500ICPSR34933MiAaIm f a u cr mn mmmmuuuu150303s2013 miu f a eng d(MiAaI)ICPSR34933MiAaIMiAaI
National Survey on Drug Use and Health, 2012
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2015-01-22Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2013ICPSR34933NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2012 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Cf.: http://doi.org/10.3886/ICPSR34933.v2
employmenticpsrhallucinogensicpsrhealth careicpsrheroinicpsrhouseholdsicpsrincomeicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsrpregnancyicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsraddictionicpsralcoholicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrcontrolled drugsicpsrcrack cocaineicpsrdemographic characteristicsicpsrdepression (psychology)icpsrdrinking behavioricpsrdrug abuseicpsrdrug dependenceicpsrdrug treatmenticpsrdrug useicpsrdrugsicpsrRCMD V. Health and Well-BeingNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA I. National Survey on Drug Use and Health (NSDUH)RCMD I. CrimeDSDR III. Health and MortalityICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemNACJD XI. Drugs, Alcohol, and CrimeUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)34933Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR34933.v2 nmm 22 4500ICPSR31921MiAaIm f a u cr mn mmmmuuuu150303s2011 miu f a eng d(MiAaI)ICPSR31921MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2009
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2015-01-20Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2011ICPSR31921NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR31921.v3
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrNAHDAP I. National Addiction and HIV Data Archive ProgramICPSR IX. Health Care and Health FacilitiesSAMHDA VIII. Drug Abuse Warning Network (DAWN)United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)31921Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR31921.v3 nmm 22 4500ICPSR31264MiAaIm f a u cr mn mmmmuuuu150303s2011 miu f a eng d(MiAaI)ICPSR31264MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2008
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2015-01-20Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2011ICPSR31264NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR31264.v5
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrSAMHDA VIII. Drug Abuse Warning Network (DAWN)ICPSR IX. Health Care and Health FacilitiesNAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)31264Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR31264.v5 nmm 22 4500ICPSR34083MiAaIm f a u cr mn mmmmuuuu150303s2012 miu f a eng d(MiAaI)ICPSR34083MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2010
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2015-01-20Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR34083NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR34083.v2
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrsuicideicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrICPSR IX. Health Care and Health FacilitiesNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA VIII. Drug Abuse Warning Network (DAWN)United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)34083Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR34083.v2 nmm 22 4500ICPSR33221MiAaIm f a u cr mn mmmmuuuu150303s2012 miu f a eng d(MiAaI)ICPSR33221MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2006
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2015-01-19Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR33221NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR33221.v2
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrICPSR IX. Health Care and Health FacilitiesSAMHDA VIII. Drug Abuse Warning Network (DAWN)NAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)33221Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR33221.v2 nmm 22 4500ICPSR33042MiAaIm f a u cr mn mmmmuuuu150303s2012 miu f a eng d(MiAaI)ICPSR33042MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2005
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies.
2015-01-19Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR33042NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR33042.v2
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrsuicideicpsrnonprescription drugsicpsrsubstance abuseicpsrNAHDAP I. National Addiction and HIV Data Archive ProgramICPSR IX. Health Care and Health FacilitiesSAMHDA VIII. Drug Abuse Warning Network (DAWN)United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies.Inter-university Consortium for Political and Social Research.ICPSR (Series)33042Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR33042.v2 nmm 22 4500ICPSR33041MiAaIm f a u cr mn mmmmuuuu150303s2012 miu f a eng d(MiAaI)ICPSR33041MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2004
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2015-01-19Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR33041NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR33041.v2
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrICPSR IX. Health Care and Health FacilitiesSAMHDA VIII. Drug Abuse Warning Network (DAWN)NAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)33041Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR33041.v2 nmm 22 4500ICPSR32861MiAaIm f a u cr mn mmmmuuuu150303s2012 miu f a eng d(MiAaI)ICPSR32861MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2007
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2015-01-19Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR32861NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR32861.v3
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA VIII. Drug Abuse Warning Network (DAWN)ICPSR IX. Health Care and Health FacilitiesUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)32861Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR32861.v3 nmm 22 4500ICPSR35509MiAaIm f a u cr mn mmmmuuuu150303s2014 miu f a eng d(MiAaI)ICPSR35509MiAaIMiAaI
National Survey on Drug Use and Health, 2013
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2014-11-18Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2014ICPSR35509NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2013 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Cf.: http://doi.org/10.3886/ICPSR35509.v1
addictionicpsralcoholicpsralcohol abuseicpsrincomeicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsrpregnancyicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrcontrolled drugsicpsrcrack cocaineicpsrdemographic characteristicsicpsrdepression (psychology)icpsrdrinking behavioricpsrdrug abuseicpsrdrug dependenceicpsrdrug treatmenticpsrdrug useicpsrdrugsicpsremploymenticpsrhallucinogensicpsrhealth careicpsrheroinicpsrhouseholdsicpsrRCMD V. Health and Well-BeingDSDR III. Health and MortalityRCMD I. CrimeNACJD XI. Drugs, Alcohol, and CrimeNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA I. National Survey on Drug Use and Health (NSDUH)ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)35509Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR35509.v1 nmm 22 4500ICPSR32722MiAaIm f a u cr mn mmmmuuuu150303s2011 miu f a eng d(MiAaI)ICPSR32722MiAaIMiAaI
National Survey on Drug Use and Health, 2010
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2014-09-05Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2011ICPSR32722NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2010 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Cf.: http://doi.org/10.3886/ICPSR32722.v5
drug useicpsrdrugsicpsremploymenticpsrhallucinogensicpsraddictionicpsralcoholicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrcontrolled drugsicpsrcrack cocaineicpsrdemographic characteristicsicpsrdepression (psychology)icpsrdrinking behavioricpsrdrug abuseicpsrdrug dependenceicpsrdrug treatmenticpsrhealth careicpsrheroinicpsrhouseholdsicpsrincomeicpsrmethamphetamineicpsrpregnancyicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrSAMHDA I. National Survey on Drug Use and Health (NSDUH)DSDR III. Health and MortalityICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemRCMD V. Health and Well-BeingRCMD I. CrimeNACJD XI. Drugs, Alcohol, and CrimeNAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)32722Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR32722.v5 nmm 22 4500ICPSR29621MiAaIm f a u cr mn mmmmuuuu150303s2010 miu f a eng d(MiAaI)ICPSR29621MiAaIMiAaI
National Survey on Drug Use and Health, 2009
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2014-09-05Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2010ICPSR29621NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2009 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. In the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Cf.: http://doi.org/10.3886/ICPSR29621.v5
incomeicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsralcohol consumptionicpsramphetaminesicpsrmethamphetamineicpsrbarbituratesicpsrpregnancyicpsrcocaineicpsrcontrolled drugsicpsrcrack cocaineicpsrdemographic characteristicsicpsrdepression (psychology)icpsrdrinking behavioricpsrdrug abuseicpsrdrug dependenceicpsrdrug treatmenticpsrdrug useicpsrdrugsicpsremploymenticpsrhallucinogensicpsrhealth careicpsrheroinicpsrhouseholdsicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsraddictionicpsralcoholicpsralcohol abuseicpsrtobacco useicpsrtranquilizersicpsryouthsicpsrNACJD XI. Drugs, Alcohol, and CrimeRCMD I. CrimeSAMHDA I. National Survey on Drug Use and Health (NSDUH)DSDR III. Health and MortalityRCMD V. Health and Well-BeingNAHDAP I. National Addiction and HIV Data Archive ProgramICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)29621Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR29621.v5 nmm 22 4500ICPSR26701MiAaIm f a u cr mn mmmmuuuu150303s2009 miu f a eng d(MiAaI)ICPSR26701MiAaIMiAaI
National Survey on Drug Use and Health, 2008
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2014-09-05Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2009ICPSR26701NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. Detailed NSDUH 2008 documentation is available from SAMHSA. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2008 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For this 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. A split-sample design also was included to administer separate sets of questions to assess impairment due to mental health problems. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Cf.: http://doi.org/10.3886/ICPSR26701.v5
addictionicpsralcoholicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrcontrolled drugsicpsrcrack cocaineicpsrdemographic characteristicsicpsrdepression (psychology)icpsrdrinking behavioricpsrdrug abuseicpsrdrug dependenceicpsrdrug treatmenticpsrdrug useicpsrdrugsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsrpregnancyicpsrprescription drugsicpsremploymenticpsrhallucinogensicpsrhealth careicpsrheroinicpsrhouseholdsicpsrincomeicpsrinhalantsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsrRCMD I. CrimeICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemDSDR III. Health and MortalityRCMD V. Health and Well-BeingSAMHDA I. National Survey on Drug Use and Health (NSDUH)NACJD XI. Drugs, Alcohol, and CrimeNAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)26701Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR26701.v5 nmm 22 4500ICPSR02756MiAaIm f a u cr mn mmmmuuuu150303s1999 miu f a eng d(MiAaI)ICPSR02756MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 1994
[electronic resource][United States]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2014-08-13Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1999ICPSR2756NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) survey is designed to
capture data on emergency department (ED) episodes that are induced by
or related to the use of an illicit, prescription, or over-the-counter
drug. For purposes of this collection, a drug "episode" is an ED visit
that was induced by or related to the use of an illegal drug or the
nonmedical use of a legal drug for patients aged six years and
older. A drug "mention" refers to a substance that was mentioned
during a drug-related ED episode. Because up to four drugs can be
reported for each drug abuse episode, there are more mentions than
episodes in the data. Individual persons may also be included more
than once in the data. Within each facility participating in DAWN, a
designated reporter, usually a member of the emergency department or
medical records staff, was responsible for identifying drug-related
episodes and recording and submitting data on each case. An episode
report was submitted for each patient visiting a DAWN emergency
department whose presenting problem(s) was/were related to their own
drug use. DAWN produces estimates of drug-related emergency department
visits for 50 specific drugs, drug categories, or combinations of
drugs, including the following: acetaminophen, alcohol in combination
with other drugs, alprazolam, amitriptyline, amphetamines, aspirin,
cocaine, codeine, diazepam, diphenhydramine, fluoxetine,
heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam,
marijuana/hashish, methadone, methamphetamine, and PCP/PCP in
combination with other drugs. The use of alcohol alone is not
reported. The route of administration and form of drug used (e.g.,
powder, tablet, liquid) are included for each drug. Data collected for
DAWN also include drug use motive and total drug mentions in the
episode, as well as race, age, patient disposition, reason for ED
visit, and day of the week, quarter, and year of episode.
Cf.: http://doi.org/10.3886/ICPSR02756.v2
demographic characteristicsicpsrsubstance abuseicpsrdrug abuseicpsrdrug dependenceicpsrdrug overdoseicpsrdrug useicpsremergenciesicpsremergency servicesicpsrhealth behavioricpsrhospitalizationicpsrNAHDAP I. National Addiction and HIV Data Archive ProgramICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemSAMHDA VIII. Drug Abuse Warning Network (DAWN)NACJD XI. Drugs, Alcohol, and CrimeICPSR XVI.A. Social Indicators, United StatesUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)2756Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02756.v2 nmm 22 4500ICPSR02834MiAaIm f a u cr mn mmmmuuuu150303s1999 miu f a eng d(MiAaI)ICPSR02834MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 1997
[electronic resource][United States]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2014-08-13Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1999ICPSR2834NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) survey is designed to
capture data on emergency department (ED) episodes that are induced by
or related to the use of an illicit, prescription, or over-the-counter
drug. For purposes of this collection, a drug "episode" is an ED visit
that was induced by or related to the use of an illegal drug or the
nonmedical use of a legal drug for patients aged six years and
older. A drug "mention" refers to a substance that was mentioned
during a drug-related ED episode. Because up to four drugs can be
reported for each drug abuse episode, there are more mentions than
episodes in the data. Individual persons may also be included more
than once in the data. Within each facility participating in DAWN, a
designated reporter, usually a member of the emergency department or
medical records staff, was responsible for identifying drug-related
episodes and recording and submitting data on each case. An episode
report was submitted for each patient visiting a DAWN emergency
department whose presenting problem(s) was/were related to their own
drug use. DAWN produces estimates of drug-related emergency department
visits for 50 specific drugs, drug categories, or combinations of
drugs, including the following: acetaminophen, alcohol in combination
with other drugs, alprazolam, amitriptyline, amphetamines, aspirin,
cocaine, codeine, diazepam, diphenhydramine, fluoxetine,
heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam,
marijuana/hashish, methadone, methamphetamine, and PCP/PCP in
combination with other drugs. The use of alcohol alone is not
reported. The route of administration and form of drug used (e.g.,
powder, tablet, liquid) are included for each drug. Data collected for
DAWN also include drug use motive and total drug mentions in the
episode, as well as race, age, patient disposition, reason for ED
visit, and day of the week, quarter, and year of episode.
Cf.: http://doi.org/10.3886/ICPSR02834.v2
emergency servicesicpsrhealth behavioricpsrhospitalizationicpsrdemographic characteristicsicpsrsubstance abuseicpsrdrug abuseicpsrdrug dependenceicpsrdrug overdoseicpsrdrug useicpsremergenciesicpsrSAMHDA VIII. Drug Abuse Warning Network (DAWN)ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemNAHDAP I. National Addiction and HIV Data Archive ProgramICPSR XVI.A. Social Indicators, United StatesNACJD XI. Drugs, Alcohol, and CrimeUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)2834Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02834.v2 nmm 22 4500ICPSR34481MiAaIm f a u cr mn mmmmuuuu150303s2012 miu f a eng d(MiAaI)ICPSR34481MiAaIMiAaI
National Survey on Drug Use and Health, 2011
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2014-05-19Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2012ICPSR34481NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2011 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Cf.: http://doi.org/10.3886/ICPSR34481.v3
alcohol abuseicpsraddictionicpsralcoholicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrcontrolled drugsicpsrcrack cocaineicpsrdemographic characteristicsicpsrdepression (psychology)icpsrdrinking behavioricpsrdrug abuseicpsrdrug dependenceicpsrdrug treatmenticpsrdrug useicpsrdrugsicpsremploymenticpsrhallucinogensicpsrhealth careicpsrheroinicpsrhouseholdsicpsrincomeicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsrpregnancyicpsryouthsicpsrNACJD XI. Drugs, Alcohol, and CrimeRCMD I. CrimeRCMD V. Health and Well-BeingDSDR III. Health and MortalityNAHDAP I. National Addiction and HIV Data Archive ProgramICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemSAMHDA I. National Survey on Drug Use and Health (NSDUH)DSDR XII. Childhood ObesityUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)34481Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR34481.v3 nmm 22 4500ICPSR34565MiAaIm f a u cr mn mmmmuuuu150303s2013 miu f a eng d(MiAaI)ICPSR34565MiAaIMiAaI
Drug Abuse Warning Network (DAWN), 2011
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality
2013-08-09Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2013ICPSR34565NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.
DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit.
The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.
Cf.: http://doi.org/10.3886/ICPSR34565.v2
alcoholicpsrdemographic characteristicsicpsrdetoxificationicpsrdrug overdoseicpsrdrug useicpsremergency departmentsicpsrenergy drinksicpsrnonprescription drugsicpsrsubstance abuseicpsrsuicideicpsrNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA VIII. Drug Abuse Warning Network (DAWN)ICPSR IX. Health Care and Health FacilitiesUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and QualityInter-university Consortium for Political and Social Research.ICPSR (Series)34565Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR34565.v2 nmm 22 4500ICPSR04596MiAaIm f a u cr mn mmmmuuuu150303s2006 miu f a eng d(MiAaI)ICPSR04596MiAaIMiAaI
National Survey on Drug Use and Health, 2005
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-06-24Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2006ICPSR4596NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Survey on Drug Use and Health (NSDUH) series
(formerly titled National Household Survey on Drug Abuse) primarily
measures the prevalence and correlates of drug use in the United
States. The surveys are designed to provide quarterly, as well as
annual, estimates. Information is provided on the use of illicit
drugs, alcohol, and tobacco among members of United States households
aged 12 and older. Questions included age at first use as well as
lifetime, annual, and past-month usage for the following drug classes:
marijuana, cocaine (and crack), hallucinogens, heroin, inhalants,
alcohol, tobacco, and nonmedical use of prescription drugs, including
pain relievers, tranquilizers, stimulants, and sedatives. The survey
covered substance abuse treatment history and perceived need for
treatment, and included questions from the Diagnostic and Statistical
Manual (DSM) of Mental Disorders that allow diagnostic criteria to be
applied. The survey included questions concerning treatment for both
substance abuse and mental health related disorders. Respondents were
also asked about personal and family income sources and amounts,
health care access and coverage, illegal activities and arrest record,
problems resulting from the use of drugs, and needle-sharing.
Questions introduced in previous administrations were retained in the
2005 survey, including questions asked only of respondents aged 12 to
17. These "youth experiences" items covered a variety of topics, such
as neighborhood environment, illegal activities, drug use by friends,
social support, extracurricular activities, exposure to substance
abuse prevention and education programs, and perceived adult attitudes
toward drug use and activities such as school work. Several measures
focused on prevention-related themes in this section. Also retained
were questions on mental health and access to care, perceived risk of
using drugs, perceived availability of drugs, driving and personal
behavior, and cigar smoking. Questions on the tobacco brand used most
often were introduced with the 1999 survey. Background information
includes gender, race, age, ethnicity, marital status, educational
level, job status, veteran status, and current household composition.
Cf.: http://doi.org/10.3886/ICPSR04596.v4
addictionicpsralcoholicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrcontrolled drugsicpsrcrack cocaineicpsrdemographic characteristicsicpsrdepression (psychology)icpsrdrinking behavioricpsrdrug abuseicpsrdrug dependenceicpsrdrug treatmenticpsrdrug useicpsrdrugsicpsrhallucinogensicpsrheroinicpsrhouseholdsicpsrincomeicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsrNAHDAP I. National Addiction and HIV Data Archive ProgramICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemFENWAY I. Fenway Archive ProjectNACJD XI. Drugs, Alcohol, and CrimeRCMD V. Health and Well-BeingSAMHDA I. National Survey on Drug Use and Health (NSDUH)RCMD I. CrimeUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)4596Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR04596.v4 nmm 22 4500ICPSR21240MiAaIm f a u cr mn mmmmuuuu150303s2007 miu f a eng d(MiAaI)ICPSR21240MiAaIMiAaI
National Survey on Drug Use and Health, 2006
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-06-21Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2007ICPSR21240NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Survey on Drug Use and Health (NSDUH) series
(formerly titled National Household Survey on Drug Abuse) primarily
measures the prevalence and correlates of drug use in the United
States. The surveys are designed to provide quarterly, as well as
annual, estimates. Information is provided on the use of illicit
drugs, alcohol, and tobacco among members of United States households
aged 12 and older. Questions included age at first use as well as
lifetime, annual, and past-month usage for the following drug classes:
marijuana, cocaine (and crack), hallucinogens, heroin, inhalants,
alcohol, tobacco, and nonmedical use of prescription drugs, including
pain relievers, tranquilizers, stimulants, and sedatives. The survey
covered substance abuse treatment history and perceived need for
treatment, and included questions from the Diagnostic and Statistical
Manual (DSM) of Mental Disorders that allow diagnostic criteria to be
applied. The survey included questions concerning treatment for both
substance abuse and mental health related disorders. Respondents were
also asked about personal and family income sources and amounts,
health care access and coverage, illegal activities and arrest record,
problems resulting from the use of drugs, and needle-sharing.
Questions introduced in previous administrations were retained in the
2006 survey, including questions asked only of respondents aged 12 to
17. These "youth experiences" items covered a variety of topics, such
as neighborhood environment, illegal activities, drug use by friends,
social support, extracurricular activities, exposure to substance
abuse prevention and education programs, and perceived adult attitudes
toward drug use and activities such as school work. Several measures
focused on prevention-related themes in this section. Also retained
were questions on mental health and access to care, perceived risk of
using drugs, perceived availability of drugs, driving and personal
behavior, and cigar smoking. Questions on the tobacco brand used most
often were introduced with the 1999 survey. Background information
includes gender, race, age, ethnicity, marital status, educational
level, job status, veteran status, and current household composition.
Cf.: http://doi.org/10.3886/ICPSR21240.v6
addictionicpsralcoholicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrcontrolled drugsicpsrcrack cocaineicpsrdemographic characteristicsicpsrdepression (psychology)icpsrdrinking behavioricpsrdrug abuseicpsrdrug dependenceicpsrdrug treatmenticpsrdrug useicpsrdrugsicpsremploymenticpsrhallucinogensicpsrhealth careicpsrheroinicpsrhouseholdsicpsrincomeicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsrpregnancyicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsrRCMD V. Health and Well-BeingRCMD I. CrimeICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA I. National Survey on Drug Use and Health (NSDUH)NACJD XI. Drugs, Alcohol, and CrimeUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)21240Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR21240.v6 nmm 22 4500ICPSR04373MiAaIm f a u cr mn mmmmuuuu150303s2006 miu f a eng d(MiAaI)ICPSR04373MiAaIMiAaI
National Survey on Drug Use and Health, 2004
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-06-21Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2006ICPSR4373NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Survey on Drug Use and Health (NSDUH) series
(formerly titled National Household Survey on Drug Abuse) measures the
prevalence and correlates of drug use in the United States. The
surveys are designed to provide quarterly, as well as annual,
estimates. Information is provided on the use of illicit drugs,
alcohol, and tobacco among members of United States households aged 12
and older. Questions included age at first use as well as lifetime,
annual, and past-month usage for the following drug classes:
marijuana, cocaine (and crack), hallucinogens, heroin, inhalants,
alcohol, tobacco, and nonmedical use of prescription drugs, including
pain relievers, tranquilizers, stimulants, and sedatives. The survey
covered substance abuse treatment history and perceived need for
treatment, and included questions from the Diagnostic and Statistical
Manual (DSM) of Mental Disorders that allow diagnostic criteria to be
applied. The survey included questions concerning treatment for both
substance abuse and mental health related disorders. Respondents were
also asked about personal and family income sources and amounts,
health care access and coverage, illegal activities and arrest record,
problems resulting from the use of drugs, and needle-sharing.
Questions introduced in previous administrations were retained in the
2004 survey, including questions asked only of respondents aged 12 to
17. These "youth experiences" items covered a variety of topics, such
as neighborhood environment, illegal activities, drug use by friends,
social support, extracurricular activities, exposure to substance
abuse prevention and education programs, and perceived adult attitudes
toward drug use and activities such as school work. Several measures
focused on prevention-related themes in this section. Also retained
were questions on mental health and access to care, perceived risk of
using drugs, perceived availability of drugs, driving and personal
behavior, and cigar smoking. Questions on the tobacco brand used most
often were introduced with the 1999 survey and retained through the
2003 survey. Background information includes gender, race, age,
ethnicity, marital status, educational level, job status, veteran
status, and current household composition. In addition, in 2004 Adult and Adolescent Mental Health modules were added.
Cf.: http://doi.org/10.3886/ICPSR04373.v3
drug treatmenticpsrdrug useicpsrdrugsicpsrhallucinogensicpsrheroinicpsrhouseholdsicpsrincomeicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsraddictionicpsralcoholicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrcontrolled drugsicpsrcrack cocaineicpsrdemographic characteristicsicpsrdepression (psychology)icpsrdrinking behavioricpsrdrug abuseicpsrdrug dependenceicpsrSAMHDA I. National Survey on Drug Use and Health (NSDUH)ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemNACJD XI. Drugs, Alcohol, and CrimeRCMD V. Health and Well-BeingRCMD I. CrimeNAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)4373Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR04373.v3 nmm 22 4500ICPSR23782MiAaIm f a u cr mn mmmmuuuu150303s2008 miu f a eng d(MiAaI)ICPSR23782MiAaIMiAaI
National Survey on Drug Use and Health, 2007
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-06-20Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2008ICPSR23782NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Survey on Drug Use and Health (NSDUH) series
(formerly titled National Household Survey on Drug Abuse) primarily
measures the prevalence and correlates of drug use in the United
States. The surveys are designed to provide quarterly, as well as
annual, estimates. Information is provided on the use of illicit
drugs, alcohol, and tobacco among members of United States households
aged 12 and older. Questions included age at first use as well as
lifetime, annual, and past-month usage for the following drug classes:
marijuana, cocaine (and crack), hallucinogens, heroin, inhalants,
alcohol, tobacco, and nonmedical use of prescription drugs, including
pain relievers, tranquilizers, stimulants, and sedatives. The survey
covered substance abuse treatment history and perceived need for
treatment, and included questions from the Diagnostic and Statistical
Manual (DSM) of Mental Disorders that allow diagnostic criteria to be
applied. The survey included questions concerning treatment for both
substance abuse and mental health related disorders. Respondents were
also asked about personal and family income sources and amounts,
health care access and coverage, illegal activities and arrest record,
problems resulting from the use of drugs, and needle-sharing.
Questions introduced in previous administrations were retained in the
2007 survey, including questions asked only of respondents aged 12 to
17. These "youth experiences" items covered a variety of topics, such
as neighborhood environment, illegal activities, drug use by friends,
social support, extracurricular activities, exposure to substance
abuse prevention and education programs, and perceived adult attitudes
toward drug use and activities such as school work. Several measures
focused on prevention-related themes in this section. Also retained
were questions on mental health and access to care, perceived risk of
using drugs, perceived availability of drugs, driving and personal
behavior, and cigar smoking. Questions on the tobacco brand used most
often were introduced with the 1999 survey. Background information
includes gender, race, age, ethnicity, marital status, educational
level, job status, veteran status, and current household composition.
Cf.: http://doi.org/10.3886/ICPSR23782.v4
addictionicpsralcoholicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrcontrolled drugsicpsrcrack cocaineicpsrdemographic characteristicsicpsrdepression (psychology)icpsrdrinking behavioricpsrdrug abuseicpsrdrug dependenceicpsrdrug treatmenticpsrdrug useicpsrdrugsicpsremploymenticpsrhallucinogensicpsrhealth careicpsrheroinicpsrhouseholdsicpsrincomeicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsrpregnancyicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsrRCMD V. Health and Well-BeingDSDR III. Health and MortalityNACJD XI. Drugs, Alcohol, and CrimeNAHDAP I. National Addiction and HIV Data Archive ProgramRCMD I. CrimeICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemSAMHDA I. National Survey on Drug Use and Health (NSDUH)United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)23782Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR23782.v4 nmm 22 4500ICPSR06949MiAaIm f a u cr mn mmmmuuuu150303s1997 miu f a eng d(MiAaI)ICPSR06949MiAaIMiAaI
National Household Survey on Drug Abuse, 1994
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-06-20Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1997ICPSR6949NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
This series measures the prevalence and correlates of drug
use in the United States. The surveys are designed to provide
quarterly, as well as annual, estimates. Information is provided on
the use of illicit drugs, alcohol, and tobacco among members of United
States households aged 12 and older. Questions include age at first
use as well as lifetime, annual, and past-month usage for the
following drug classes: marijuana, cocaine (and crack), hallucinogens,
heroin, inhalants, alcohol, tobacco, anabolic steroids, nonmedical use
of prescription-type psychotherapeutic drugs, and polysubstance
use. Respondents were also asked about substance abuse treatment
history, illegal activities, problems resulting from use of drugs,
perceptions of the risks involved, and personal and family income
sources and amounts. Questions on need for treatment for drug or
alcohol use, criminal record, and needle-sharing were also included.
A split sample design using two questionnaires was employed with the
1994 NHSDA. The 1994-A questionnaire is comparable to NHSDA
questionnaires prior to 1994 and contains all of the core questions
from previous NHSDAs. The 1994-B questionnaire, which includes new
questions on access to care and mental health, incorporates
significant changes from the previous questionnaires and can only be
compared to NHSDA surveys in 1995 and beyond. The changes to the
questionnaire were undertaken in order to facilitate respondent
cooperation, enhance the clarity of questions, improve the accuracy of
responses, and increase the reliability of measurements across survey
years. In addition, a rural supplementary sample was included in 1994
to obtain substance abuse prevalence estimates for rural areas.
Demographic data include gender, race, age, ethnicity, marital status,
motor vehicle use, educational level, job status, income level,
veteran status, and past and current household composition.
Cf.: http://doi.org/10.3886/ICPSR06949.v2
alcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrdemographic characteristicsicpsrdrug abuseicpsrdrug useicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsrdrugsicpsrhallucinogensicpsrhealth insuranceicpsrhealth statusicpsrheroinicpsrhouseholdsicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsroffensesicpsrprescriptions drugsicpsrsedativesicpsrsmokingicpsrsteroidsicpsrSAMHDA I. National Survey on Drug Use and Health (NSDUH)NAHDAP I. National Addiction and HIV Data Archive ProgramRCMD V. Health and Well-BeingNACJD XI. Drugs, Alcohol, and CrimeRCMD I. CrimeICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)6949Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR06949.v2 nmm 22 4500ICPSR06950MiAaIm f a u cr mn mmmmuuuu150303s1997 miu f a eng d(MiAaI)ICPSR06950MiAaIMiAaI
National Household Survey on Drug Abuse, 1995
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-05-06Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1997ICPSR6950NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
This series measures the prevalence and correlates of drug
use in the United States. The surveys are designed to provide
quarterly, as well as annual, estimates. Information is provided on
the use of illicit drugs, alcohol, and tobacco among members of United
States households aged 12 and older. Questions include age at first
use as well as lifetime, annual, and past-month usage for the
following drug classes: marijuana, cocaine (and crack), hallucinogens,
heroin, inhalants, alcohol, tobacco, anabolic steroids, nonmedical use
of prescription drugs including psychotherapeutics, and polysubstance
use. Respondents were also asked about substance abuse treatment
history, illegal activities, problems resulting from use of drugs,
perceptions of the risks involved, personal and family income sources
and amounts, need for treatment for drug or alcohol use, criminal
record, and needle-sharing. Questions on mental health and access to
care, which were introduced in the 1994-B questionnaire (see NATIONAL
HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in
this administration of the survey. Demographic data include gender,
race, age, ethnicity, marital status, motor vehicle use, educational
level, job status, income level, veteran status, and past and current
household composition.
Cf.: http://doi.org/10.3886/ICPSR06950.v2
drug useicpsrdrugsicpsrhallucinogensicpsrhealth careicpsrhealth insuranceicpsrheroinicpsrhouseholdsicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsroffensesicpsrpatientsicpsrprescriptions drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsrtreatmenticpsryouthsicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrdemographic characteristicsicpsrdrug abuseicpsrRCMD I. CrimeNACJD XI. Drugs, Alcohol, and CrimeDSDR XII. Childhood ObesityNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA I. National Survey on Drug Use and Health (NSDUH)RCMD V. Health and Well-BeingICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)6950Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR06950.v2 nmm 22 4500ICPSR06887MiAaIm f a u cr mn mmmmuuuu150303s1997 miu f a eng d(MiAaI)ICPSR06887MiAaIMiAaI
National Household Survey on Drug Abuse, 1992
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-05-06Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1997ICPSR6887NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
This series measures the prevalence and correlates of drug
use in the United States. The surveys are designed to provide
quarterly, as well as annual, estimates. Information is provided on
the use of illicit drugs, alcohol, anabolic steroids, and tobacco
among members of United States households aged 12 and older. Data are
also provided on treatment for drug use and on illegal activities
related to drug use. Questions include age at first use, as well as
lifetime, annual, and past-month usage for the following drug classes:
marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco,
and nonmedical use of psychotherapeutics. Respondents were also asked
about problems resulting from their use of drugs, alcohol, and
tobacco, their perceptions of the risks involved, insurance coverage,
and personal and family income sources and amounts. Demographic data
include gender, race, ethnicity, educational level, job status, income
level, household composition, and population density.
Cf.: http://doi.org/10.3886/ICPSR06887.v3
drug abuseicpsrdrug useicpsrdrugsicpsrhallucinogensicpsrheroinicpsrhouseholdsicpsrinhalantsicpsrmarijuanaicpsrmethamphetamineicpsrbarbituratesicpsrcocaineicpsrdemographic characteristicsicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrsteroid useicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsrRCMD I. CrimeICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemRCMD V. Health and Well-BeingSAMHDA I. National Survey on Drug Use and Health (NSDUH)NACJD XI. Drugs, Alcohol, and CrimeNAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)6887Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR06887.v3 nmm 22 4500ICPSR06852MiAaIm f a u cr mn mmmmuuuu150303s1997 miu f a eng d(MiAaI)ICPSR06852MiAaIMiAaI
National Household Survey on Drug Abuse, 1993
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-05-06Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1997ICPSR6852NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
This series measures the prevalence and correlates of drug
use in the United States. The surveys are designed to provide
quarterly, as well as annual, estimates. Information is provided on
the use of illicit drugs, alcohol, anabolic steroids, and tobacco
among members of United States households aged 12 and older. Data are
also provided on treatment for drug use and on illegal activities
related to drug use. Questions include age at first use, as well as
lifetime, annual, and past-month usage for the following drug classes:
marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco,
and nonmedical use of psychotherapeutics. Respondents were also asked
about problems resulting from their use of drugs, alcohol, and
tobacco, their perceptions of the risks involved, insurance coverage,
and personal and family income sources and amounts. Demographic data
include gender, race, ethnicity, educational level, job status, income
level, household composition, and population density.
Cf.: http://doi.org/10.3886/ICPSR06852.v2
alcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrdemographic characteristicsicpsrdrug abuseicpsrdrug useicpsrdrugsicpsrhallucinogensicpsrheroinicpsrhouseholdsicpsrinhalantsicpsrmarijuanaicpsrmethamphetamineicpsroffensesicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrsteroid useicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsrICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemRCMD V. Health and Well-BeingNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA I. National Survey on Drug Use and Health (NSDUH)RCMD I. CrimeNACJD XI. Drugs, Alcohol, and CrimeUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)6852Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR06852.v2 nmm 22 4500ICPSR02755MiAaIm f a u cr mn mmmmuuuu150303s1999 miu f a eng d(MiAaI)ICPSR02755MiAaIMiAaI
National Household Survey on Drug Abuse, 1997
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-05-06Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1999ICPSR2755NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
This series measures the prevalence and correlates of drug
use in the United States. The surveys are designed to provide
quarterly, as well as annual, estimates. Information is provided on
the use of illicit drugs, alcohol, and tobacco among members of United
States households aged 12 and older. Questions include age at first
use as well as lifetime, annual, and past-month usage for the
following drug classes: marijuana, cocaine (and crack), hallucinogens,
heroin, inhalants, alcohol, tobacco, and nonmedical use of
prescription drugs, including psychotherapeutics. Respondents were
also asked about substance abuse treatment history, illegal
activities, problems resulting from the use of drugs, personal and
family income sources and amounts, need for treatment for drug or
alcohol use, criminal record, and needle-sharing. Questions on mental
health and access to care, which were introduced in the 1994-B
questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994
[ICPSR 6949]), were retained in this administration of the survey. In
1996, the section on risk/availability of drugs was reintroduced, and
sections on driving behavior and personal behavior were added (see
NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1996 [ICPSR 2391]). The 1997
questionnaire continued the risk/availability section along with new
items about the use of cigars, people present when respondents used
marijuana or cocaine for the first time (if applicable), reasons for
using these two drugs the first time, reasons for using these two
drugs in the past year, reasons for discontinuing use of these two
drugs (for lifetime but not past-year users), and reasons respondents
never used these two drugs. In addition, a new series of questions
asked only of respondents aged 12 to 17 was introduced. These items
covered a variety of topics that may be associated with substance use
and related behaviors, such as exposure to substance abuse prevention
and education programs, gang involvement, relationship with parents,
and substance use by friends. Demographic data include gender, race,
age, ethnicity, marital status, educational level, job status, income
level, veteran status, and current household composition.
Cf.: http://doi.org/10.3886/ICPSR02755.v3
demographic characteristicsicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrdrug abuseicpsrdrug useicpsrdrugsicpsrhallucinogensicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsroffensesicpsrprescriptions drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsrhealth careicpsrhealth insuranceicpsrheroinicpsrhouseholdsicpsrinhalantsicpsrNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA I. National Survey on Drug Use and Health (NSDUH)RCMD I. CrimeRCMD V. Health and Well-BeingICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemNACJD XI. Drugs, Alcohol, and CrimeUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)2755Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02755.v3 nmm 22 4500ICPSR02391MiAaIm f a u cr mn mmmmuuuu150303s1998 miu f a eng d(MiAaI)ICPSR02391MiAaIMiAaI
National Household Survey on Drug Abuse, 1996
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-05-06Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1998ICPSR2391NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
This series measures the prevalence and correlates of drug
use in the United States. The surveys are designed to provide
quarterly, as well as annual, estimates. Information is provided on
the use of illicit drugs, alcohol, and tobacco among members of United
States households aged 12 and older. Questions include age at first
use as well as lifetime, annual, and past-month usage for the
following drug classes: marijuana, cocaine (and crack), hallucinogens,
heroin, inhalants, alcohol, tobacco, and nonmedical use of
prescription drugs, including psychotherapeutics. Respondents were
also asked about substance abuse treatment history, illegal
activities, problems resulting from the use of drugs, personal and
family income sources and amounts, need for treatment for drug or
alcohol use, criminal record, and needle-sharing. Questions on mental
health and access to care, which were introduced in the 1994-B
questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994
[ICPSR 6949]), were retained in this administration of the survey. In
1996, the section on risk/availability of drugs was reintroduced, and
sections on driving behavior and personal behavior were
added. Demographic data include gender, race, age, ethnicity, marital
status, educational level, job status, income level, veteran status,
and current household composition.
Cf.: http://doi.org/10.3886/ICPSR02391.v2
alcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrprescription drugsicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtranquilizersicpsryouthsicpsrcocaineicpsrcrimeicpsrdemographic characteristicsicpsrdrug abuseicpsrdrug useicpsrdrugsicpsrhallucinogensicpsrhealth careicpsrhealth insuranceicpsrheroinicpsrHIVicpsrhouseholdsicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsrFENWAY VI. Studies That Include Heterosexual PopulationsNAHDAP I. National Addiction and HIV Data Archive ProgramICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemSAMHDA I. National Survey on Drug Use and Health (NSDUH)RCMD I. CrimeRCMD V. Health and Well-BeingNACJD XI. Drugs, Alcohol, and CrimeUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)2391Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02391.v2 nmm 22 4500ICPSR02934MiAaIm f a u cr mn mmmmuuuu150303s2000 miu f a eng d(MiAaI)ICPSR02934MiAaIMiAaI
National Household Survey on Drug Abuse, 1998
[electronic resource]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2013-05-06Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2000ICPSR2934NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The National Household Survey on Drug Abuse (NHSDA) series
measures the prevalence and correlates of drug use in the United
States. The surveys are designed to provide quarterly, as well as
annual, estimates. Information is provided on the use of illicit
drugs, alcohol, and tobacco among members of United States households
aged 12 and older. Questions include age at first use as well as
lifetime, annual, and past-month usage for the following drug classes:
marijuana, cocaine (and crack), hallucinogens, heroin, inhalants,
alcohol, tobacco, and nonmedical use of prescription drugs, including
psychotherapeutics. Respondents were also asked about personal and
family income sources and amounts, substance abuse treatment history,
illegal activities, problems resulting from the use of drugs, need for
treatment for drug or alcohol use, criminal record, and
needle-sharing. Questions on mental health and access to care, which
were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD
SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this
administration of the survey. Also retained was the section on
risk/availability of drugs that was reintroduced in 1996, and sections
on driving behavior and personal behavior were added (see NATIONAL
HOUSEHOLD SURVEY ON DRUG ABUSE, 1996 [ICPSR 2391]). The 1997
questionnaire (NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1997 [ICPSR
2755]) introduced new items that the 1998 NHSDA continued on cigar
smoking, people who were present when respondents used marijuana or
cocaine for the first time (if applicable), reasons for using these
two drugs the first time, reasons for using these two drugs in the
past year, reasons for discontinuing use of these two drugs (for
lifetime but not past-year users), and reasons respondents never used
these two drugs. Both the 1997 and 1998 NHSDAs had a series of
questions that were asked only of respondents aged 12 to 17. These
items covered a variety of topics that may be associated with
substance use and related behaviors, such as exposure to substance
abuse prevention and education programs, gang involvement,
relationship with parents, and substance use by friends. Demographic
data include gender, race, age, ethnicity, marital status, educational
level, job status, income level, veteran status, and current household
composition.
Cf.: http://doi.org/10.3886/ICPSR02934.v4
alcoholicpsralcohol abuseicpsralcohol consumptionicpsramphetaminesicpsrbarbituratesicpsrcocaineicpsrdemographic characteristicsicpsrdrug abuseicpsrdrug useicpsrdrugsicpsrhallucinogensicpsrhealth careicpsrhealth insuranceicpsrheroinicpsrhouseholdsicpsrinhalantsicpsrmarijuanaicpsrmental healthicpsrmental health servicesicpsrmethamphetamineicpsrprescription drugsicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuseicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsryouthsicpsrSAMHDA I. National Survey on Drug Use and Health (NSDUH)RCMD V. Health and Well-BeingNACJD XI. Drugs, Alcohol, and CrimeRCMD I. CrimeICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemNAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)2934Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02934.v4 nmm 22 4500ICPSR02258MiAaIm f a u cr mn mmmmuuuu150303s2000 miu f a eng d(MiAaI)ICPSR02258MiAaIMiAaI
Drug Abuse Treatment Outcome Study (DATOS), 1991-1994
[electronic resource][United States]
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
2010-02-16Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2000ICPSR2258NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
Drug-Abuse Treatment Outcomes Study (DATOS) is a
prospective study designed to determine the outcomes of adult drug
abuse treatment delivered in typical, stable, community-based programs
and to provide comprehensive information on continuing and new
questions about the effectiveness of drug abuse treatment for adults
currently available in a variety of publicly funded and private
programs. The study examined the role of treatment outcomes and
program type, client characteristics (including dependence, treatment
history, and physical and mental health comorbidities), treatment
received (e.g., length and intensity of services provided),
therapeutic approaches, provision of aftercare, and research on the
components of effective treatment, including factors that engage and
retain clients in programs. Four types of programs were included:
outpatient methadone (OPM), short-term inpatient (STI), long-term
residential (LTR), and outpatient drug-free (ODF). Respondents were
sampled from among adults admitted to drug abuse treatment programs in
11 representative U.S. cities during 1991-1993.
Clients entering treatment completed two comprehensive intake
interviews (Intake 1 and Intake 2), approximately one week apart. This
information is provided in Parts 1 and 2 of the data collection. These
interviews were designed to obtain baseline data on drug use and other
behaviors, as well as information on background and demographic
characteristics, patterns of dependence, living situation and child
custody status, education and training, income and expenditures, and
HIV risk behaviors, along with assessments of dependence, mental
health, physical health, and social functioning. Data on criminal
justice status and criminal behavior are reported in Part 5, Illegal
Activities Data, and are drawn from the Intake 1 interview. Data
reflecting during-treatment progress, including service delivery and
client satisfaction, were collected in the one-, three-, and six-month
in-treatment interviews (Parts 3, 4, and 8). The 12-Month
Post-Treatment Follow-Up Interview (Part 6) replicated many of the
intake questions and focused on key behaviors in the year following
treatment. Part 7 includes variables for time in treatment and
interview availability indicators. The 12-Month Follow-Up Urine Result
data (Part 9) provide the results from urine sample tests that were
given to a sample of subjects at the time of the 12-Month Follow-Up
Interview. Urine specimens were tested for eight categories of drugs
(amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine
metabolite, methaqualone, opiates, and phencyclidine). The drugs
covered in the study were alcohol, tobacco, marijuana (hashish, THC),
hallucinogens or psychedelics such as LSD, mescaline, and PCP, cocaine
(including crack), heroin, narcotics or opiates such as morphine,
codeine, Demerol, Dilaudid, and Talwin, downers or depressants such as
sedatives, barbiturates, and tranquilizers, amphetamines or other
stimulants such as speed or diet pills, and other drugs. Part 10 contains data for 1393 clients who were interviewed 5 years post treatment. This part contains many of the same types of questions asked during previous interviews.
Cf.: http://doi.org/10.3886/ICPSR02258.v5
AIDSicpsrcriminal historiesicpsrdemographic characteristicsicpsrdrug abuseicpsrdrug treatmenticpsrHIVicpsrmental healthicpsrphysical conditionicpsrtreatment outcomeicpsrtreatment programsicpsrICPSR XVI.A. Social Indicators, United StatesSAMHDA VII. Drug Abuse Treatment Outcome Study (DATOS)NAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. National Institutes of Health. National Institute on Drug AbuseInter-university Consortium for Political and Social Research.ICPSR (Series)2258Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02258.v5 nmm 22 4500ICPSR02347MiAaIm f a u cr mn mmmmuuuu150303s1998 miu f a eng d(MiAaI)ICPSR02347MiAaIMiAaI
Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1992
[electronic resource]Drug Use Among DC Women Delivering Live Births in DC Hospitals
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
2008-12-15Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1998ICPSR2347NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Washington, DC, Metropolitan Area Drug Study (DC*MADS) was conducted
in 1991, and included special analyses of homeless and transient
delivering live births in the DC hospitals. DC*MADS was undertaken to
assess the full extent of the drug problem in one metropolitan
area. The study was comprised of 16 separate studies that focused on
different sub-groups, many of which are typically not included or are
underrepresented in household surveys.
The DC*MADS: Drug Use
Among Women Delivering Livebirths in DC Hospitals was designed to
examine the nature and extent of drug use among women delivering live
births in eight Washington, DC, hospitals participating in the
study. Data from the questionnaires include prenatal care, health
problems during pregnancy, pregnancy drug use history, needle use,
polysubstance use, patterns of use, respondent's general experiences
with drug use, including perceptions of the risks and consequences of
use, occurrence of psychological and emotional problems, income and
insurance coverage, treatment experiences, and maternal and infant
outcomes. Medical records were abstracted from the women and their
infants to document medical problems. Abstracted data on the mothers
included demographics, discharge diagnoses, disposition at discharge,
and results of urine screens. Abstracted data on infants included
delivery information, status at discharge, discharge
diagnoses/procedures, and first urine toxicology screen results.
Cf.: http://doi.org/10.3886/ICPSR02347.v2
alcohol consumptionicpsrcocaineicpsrdemographic characteristicsicpsrdrug testingicpsrdrug useicpsrdrugsicpsrhallucinogensicpsrhealth care accessicpsralcoholicpsrheroinicpsrinfantsicpsrinhalantsicpsrinsurance coverageicpsrlive birthsicpsrmarijuanaicpsrmental healthicpsrpopulation characteristicsicpsrpregnancyicpsrprenatal careicpsrreproductive historyicpsrsedativesicpsrsmokingicpsrstimulantsicpsrsubstance abuse treatmenticpsrtobacco useicpsrtranquilizersicpsrurban populationicpsrwomenicpsrICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemNAHDAP I. National Addiction and HIV Data Archive ProgramNACJD XI. Drugs, Alcohol, and CrimeSAMHDA VI. Washington, DC, Metropolitan Area Drug Study (DC*MADS)ICPSR XVI.A. Social Indicators, United StatesRCMD V. Health and Well-BeingUnited States Department of Health and Human Services. National Institutes of Health. National Institute on Drug AbuseInter-university Consortium for Political and Social Research.ICPSR (Series)2347Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02347.v2 nmm 22 4500ICPSR02691MiAaIm f a u cr mn mmmmuuuu150303s2000 miu f a eng d(MiAaI)ICPSR02691MiAaIMiAaI
Services Research Outcomes Study, 1995-1996
[electronic resource][United States]
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
2008-10-29Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2000ICPSR2691NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Services Research Outcomes Study (SROS) sought to answer questions about drug treatment efficacy and to describe client characteristics. The study was designed to provide (1) a 1990 cohort of clients to use as baseline for possible changes in treatment outcomes following increased funding to the national treatment system in the 1990s, (2) a before-to-after comparison to measure outcomes of treatment provided in 1990, (3) a follow-up of drug treatment clients five years after treatment to assess the level of sustained improvements in abstinence, and (4) a first look at multiple treatment episodes before and after treatment in a 1990 population.
Part 1 is the Facility Director Interviews and covered topics such as facility staff and organization, revenue and charges, staff hours and compensation, costs, and program characteristics.
Part 2 is the Client Records Abstractions Data, which examined the client records of 2,222 individuals discharged during 1989-1990. Information was abstracted on demographic characteristics of clients, criminal justice involvement, medical conditions, drug history including intravenous drug use, urine test results, drug treatment history, treatment services, and discharge and billing information.
Part 3 consists of the Client Follow-Up Interviews, and was conducted during 1995 and 1996. This part covered the clients' entire life span, with special attention to their behavior and circumstances during the five years before entry to the index (SROS) treatment in 1989-1990 and after leaving that treatment until the time of the interview. Additional questions were asked on patterns of alcohol and drug consumption, criminal activity, employment, health, social support, and other behavior relevant to treatment goals. Drugs included cocaine, crack, heroin, nontreatment methadone, other opiates/synthetics, barbiturates, benzodiazapine, other sedatives/hypnotics, methamphetamines, other amphetamines, marijuana/hash/THC, PCP/LSD, other hallucinogens, inhalants, over-the-counter medications, and alcohol.
Cf.: http://doi.org/10.3886/ICPSR02691.v1
alcohol abuseicpsrtreatment facilitiesicpsrphysical healthicpsrtreatment outcomesicpsrtreatment programsicpsrurinalysisicpsrcriminal historiesicpsrdemographic characteristicsicpsrdrug testingicpsrdrug treatmenticpsrdrug useicpsremploymenticpsrmental healthicpsrICPSR XVI.A. Social Indicators, United StatesSAMHDA X. Services Research Outcomes StudyNAHDAP I. National Addiction and HIV Data Archive ProgramUnited States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied StudiesInter-university Consortium for Political and Social Research.ICPSR (Series)2691Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02691.v1 nmm 22 4500ICPSR02835MiAaIm f a u cr mn mmmmuuuu150303s2000 miu f a eng d(MiAaI)ICPSR02835MiAaIMiAaI
National Pregnancy and Health Survey
[electronic resource]Drug Use Among Women Delivering Live Births, 1992
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
2008-07-31Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2000ICPSR2835NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The primary objective of the National Pregnancy and Health
Survey (NPHS) was to produce national annual estimates of the
percentages and numbers of mothers of live newborns in the United
States who used selected licit and illicit drugs in the 12 months
prior to delivery. A further objective was to describe patterns of
prenatal substance use among demographic subgroups of
women. Information on demographic and socioeconomic characteristics,
obstetric history, and drug treatment of women who delivered infants
at sampled hospitals was obtained through an interviewer-administered
questionnaire, while data on substance use before and during pregnancy
were collected through a questionnaire completed by the respondent and
concealed from the interviewer. Respondents were asked about use of
the following substances: alcohol, amphetamines, analgesics, cocaine,
crack cocaine, barbiturates, hallucinogens, hashish, heroin,
marijuana, methadone, methamphetamine, sedatives, stimulants, tobacco,
and tranquilizers. Additionally, information was collected on the
respondent's pregnancy, prenatal care, delivery, previous pregnancies,
and background. Additional data were obtained from the mothers' and
infants' medical records. Urine specimens collected routinely by the
hospital on obstetric admissions were tested for selected
drugs. Finally, in a subsample of six hospitals, hair specimens were
requested from respondents to evaluate the potential of hair as a
source of toxicological data in future studies.
Cf.: http://doi.org/10.3886/ICPSR02835.v2
alcoholicpsramphetaminesicpsrcocaineicpsrdemographic characteristicsicpsrdrug testingicpsrdrug treatmenticpsrdrug useicpsreconomic indicatorsicpsrheroinicpsrhospitalsicpsrlive birthsicpsrmarijuanaicpsrmethadoneicpsrpregnancyicpsrprenatal careicpsrreproductive historyicpsrsedativesicpsrtobacco useicpsrtranquilizersicpsrurinalysisicpsrwomenicpsrNAHDAP I. National Addiction and HIV Data Archive ProgramAHRQMCC I. Multiple Chronic ConditionsSAMHDA XI. National Pregnancy and Health Survey (NPHS)DSDR XII. Childhood ObesityICPSR XVI.A. Social Indicators, United StatesUnited States Department of Health and Human Services. National Institutes of Health. National Institute on Drug AbuseInter-university Consortium for Political and Social Research.ICPSR (Series)2835Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02835.v2 nmm 22 4500ICPSR02346MiAaIm f a u cr mn mmmmuuuu150303s1998 miu f a eng d(MiAaI)ICPSR02346MiAaIMiAaI
Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1991
[electronic resource]Homeless and Transient Population
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
2008-07-24Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1998ICPSR2346NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The DC Metropolitan Area Drug Study (DC*MADS) was
conducted in 1991, and included special analyses of homeless and
transient populations and of women delivering live births in the DC
hospitals. DC*MADS was undertaken to assess the full extent of the
drug problem in one metropolitan area. The study was comprised of 16
separate studies that focused on different sub-groups, many of which
are typically not included or are underrepresented in household
surveys.
The Homeless and Transient Population
study examines the prevalence of illicit drug, alcohol, and tobacco
use among members of the homeless and transient population aged 12 and
older in the Washington, DC, Metropolitan Statistical Area (DC
MSA). The sample frame included respondents from shelters, soup
kitchens and food banks, major cluster encampments, and literally
homeless people. Data from the questionnaires include history of
homelessness, living arrangements and population movement, tobacco,
drug, and alcohol use, consequences of use, treatment history, illegal
behavior and arrest, emergency room treatment and hospital stays,
physical and mental health, pregnancy, insurance, employment and
finances, and demographics. Drug specific data include age at first
use, route of administration, needle use, withdrawal symptoms,
polysubstance use, and perceived risk.
Cf.: http://doi.org/10.3886/ICPSR02346.v2
smokingicpsrstimulantsicpsrsubstance abuse treatmenticpsrurban populationicpsrsubstance abuse treatmenticpsrhomeless personsicpsrinhalantsicpsrliving arrangementsicpsrmarijuanaicpsrheroinicpsremploymenticpsrurban populationicpsrdemographic characteristicsicpsrdrug abuseicpsrdrug related crimesicpsrdrug useicpsrdrugsicpsrcrack cocaineicpsrarrestsicpsrhallucinogensicpsrhealth insuranceicpsrmental healthicpsrmental health treatmenticpsrmethamphetaminesicpsrcocaineicpsrpregnancyicpsrprescription drugsicpsrsedativesicpsrphysical healthicpsrpopulation characteristicsicpsrRCMD V. Health and Well-BeingNACJD XI. Drugs, Alcohol, and CrimeICPSR XVI.A. Social Indicators, United StatesNAHDAP I. National Addiction and HIV Data Archive ProgramSAMHDA VI. Washington, DC, Metropolitan Area Drug Study (DC*MADS)ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemUnited States Department of Health and Human Services. National Institutes of Health. National Institute on Drug AbuseInter-university Consortium for Political and Social Research.ICPSR (Series)2346Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02346.v2 nmm 22 4500ICPSR02155MiAaIm f a u cr mn mmmmuuuu150303s1998 miu f a eng d(MiAaI)ICPSR02155MiAaIMiAaI
Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1991
[electronic resource]Household and Non-Household Populations
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
2008-07-16Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]1998ICPSR2155NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The DC Metropolitan Area Drug Study (DC*MADS) was
conducted in 1991, and included special analyses of homeless and
transient populations and of women delivering live births in the DC
hospitals. DC*MADS was undertaken to assess the full extent of the
drug problem in one metropolitan area. The study was comprised of 16
separate studies that focused on different sub-groups, many of which
are typically not included or are under-represented in household
surveys.
The DC*MADS: Household and Non-household Populations
examines the prevalence of tobacco, alcohol, and drug use among
members of household and non-household populations aged 12 and older
in the District of Columbia Metropolitan Statistical Area (DC
MSA). The study also examines the characteristics of three
drug-abusing sub-groups: crack-cocaine, heroin, and needle users. The
household sample was drawn from the 1991 National Household Survey on
Drug Abuse (NHSDA). The non-household sample was drawn from the
DC*MADS Institutionalized and Homeless and Transient Population
Studies. Data include demographics, needle use, needle-sharing, and
use of tobacco, alcohol, cocaine, crack, inhalants, marijuana, hallucinogens, heroin, sedatives, stimulants, psychotherapeutics (non-medical use), tranquilizers, and analgesics.
Cf.: http://doi.org/10.3886/ICPSR02155.v3
alcoholicpsrcocaineicpsrcrack cocaineicpsrdemographic characteristicsicpsrdrug abuseicpsrdrug useicpsrhallucinogensicpsrheroinicpsrhomeless personsicpsrinhalantsicpsrmarijuanaicpsrsedativesicpsrsmokingicpsrstimulantsicpsrtranquilizersicpsrICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice SystemICPSR XVI.A. Social Indicators, United StatesSAMHDA VI. Washington, DC, Metropolitan Area Drug Study (DC*MADS)NAHDAP I. National Addiction and HIV Data Archive ProgramNACJD XI. Drugs, Alcohol, and CrimeRCMD V. Health and Well-BeingUnited States Department of Health and Human Services. National Institutes of Health. National Institute on Drug AbuseInter-university Consortium for Political and Social Research.ICPSR (Series)2155Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02155.v3 nmm 22 4500ICPSR02778MiAaIm f a u cr mn mmmmuuuu150303s2002 miu f a eng d(MiAaI)ICPSR02778MiAaIMiAaI
Gambling Impact and Behavior Study, 1997-1999
[electronic resource][United States]
National Gambling Impact Study Commission
2007-08-28Ann Arbor, Mich.Inter-university Consortium for Political and Social Research [distributor]2002ICPSR2778NumericTitle from ICPSR DDI metadata of 2015-03-03.AVAILABLE. This study is freely available to the general public.Also available as downloadable files.
The Gambling Impact and Behavior Study investigates the
gambling behavior and attitudes of adults and youth in America, and
also estimates the effects of gambling facilities on a variety of
local economic and social indicators. Respondents were randomly
selected by a national random-digit dial (RDD) through a stratified
design by state lottery status and distances to major casino. The
study includes three independent, unlinkable data files. The adult and
youth questionnaire (Parts 1 and 2) covered areas such as demographic
information, geographic region, gambling behavior and attitudes,
motivations for gambling, gambling history, a problem-gambling
diagnostic assessment, gambling treatment experience, family/marital
status and issues, income and financial information, criminal
activity, mental and general health, and substance use. Areas of
substance abuse examined were the use of alcohol, marijuana, hashish,
cocaine, crack, methamphetamine, stimulants, tranquilizers,
amphetamines, and speed. The Community Database (Part 3) included the
following: geographic locators (latitude, longitude), availability of
gaming facilities, gaming spending estimates, employment patterns by
industry, unemployment, bankruptcy, personal income, private and
public earnings, government expenditures, income maintenance/AFDC, and
vital statistics.
Cf.: http://doi.org/10.3886/ICPSR02778.v2
attitudesicpsrcasinosicpsrdemographic characteristicsicpsreconomic indicatorsicpsrgamblingicpsrhuman behavioricpsrsocial indicatorsicpsrSAMHDA XVII. Gambling Impact and Behavior StudyICPSR XVI.A. Social Indicators, United StatesNational Gambling Impact Study CommissionInter-university Consortium for Political and Social Research.ICPSR (Series)2778Access restricted ; authentication may be required:http://doi.org/10.3886/ICPSR02778.v2